Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy
KRAS Q61 and NRAS Q61 mutations are promising predictors for OS in CRLM patients after hepatectomy. Postoperative chemotherapy may significantly benefit CRLM patients with RAS mutations, particularly those identified as high-risk.
Authors
- Baocai Xing (ORCID: https://orcid.org/0000-0002-7527-4650)
- X L Wu (ORCID: https://orcid.org/0009-0003-1498-0900)
- Kun Wang (ORCID: https://orcid.org/0000-0002-2793-7923)
- Yanyan Wang (ORCID: https://orcid.org/0000-0002-6170-0487)
- Wei Liu (ORCID: https://orcid.org/0000-0001-7118-815X)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/cam4.70168
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- National Natural Science Foundation of China